AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD-Reference-Cited by-同舟云学术

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD

Published:2019-10-04 Issue: Volume:10 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Prain Kerri,Woodhall Mark,Vincent Angela,Ramanathan Sudarshini,Barnett Michael H.,Bundell Christine S.,Parratt John D. E.,Silvestrini Roger A.,Bukhari Wajih,Brilot Fabienne,Waters Patrick,Broadley Simon A.,

Funder

Multiple Sclerosis Research Australia

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference24 articles.

1. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders;Wingerchuk;Neurology.,2015

2. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis;Lennon;Lancet.,2004

3. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system;Argyriou;Acta Neurol Scand.,2008

4. Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination;Ramanathan;Autoimmun Rev.,2016

5. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination;Ramanathan;J Neurol Neurosurg Psychiatry.,2018

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on aquaporin-4 antibody detection: the early diagnosis of neuromyelitis optica spectrum disorders;Multiple Sclerosis and Related Disorders;2024-10

2. Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGAD;Multiple Sclerosis Journal;2024-09-05

3. Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study;Journal of Neurology, Neurosurgery & Psychiatry;2024-09-04

4. Long-term outcomes of ADEM-like and tumefactive presentations of CNS demyelination: a case-comparison analysis;Journal of Neurology;2024-06-11

5. Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders;Journal of Neurology;2024-05-21